<DOC>
	<DOCNO>NCT00306982</DOCNO>
	<brief_summary>This study investigate incidence influenza , disease various possible downstream complication hospitalization emergency room visit routine annual vaccination elderly population Fluarix™ .</brief_summary>
	<brief_title>Incidence Influenza , Downstream Complications Influenza &amp; Hospitalizations Elderly Vaccinated With Fluarix™</brief_title>
	<detailed_description>This study investigate incidence influenza , disease various possible downstream complication , pneumonia , ischemic HD ( unstable angina MI ) , congestive heart failure , acute cerebrovascular disease , COPD exacerbation hospitalization emergency room visit , evaluate feasibility health outcome surveillance validity use questionnaire instrument , routine annual vaccination elderly population Fluarix™ .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Inclusion Criteria All subject must satisfy follow criterion study entry : ( 1 ) A male female age 65 year time first vaccination , ( 2 ) Subjects investigator believe comply requirement protocol ( e.g. , return followup visit , disease report phone , completion Questionnaires ) enrol study ( 3 ) Written informed consent obtain subject ( 4 ) Availability follow phone study period ( 5 ) Subjects residence status allow free mix general community . Exclusion Criteria The subject must include study : ( 1 ) history hypersensitivity previous dose influenza vaccine ( 2 ) history allergy reaction likely exacerbate component vaccine include egg , chicken protein , formaldehyde , thimerosal , gentamicin sulfate sodium deoxycholate , ( 3 ) use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Prophylaxis Influenza vaccine</keyword>
</DOC>